Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discovery

Biotechnology companies are uncovering new methods to develop drugs across a range of therapeutic areas. Looking to demonstrate a commitment to drug discovery and moving away from traditional laboratory animal…

Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”

It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…

Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…

Organovo Presents New Data on Stem Cell-Based Bioprinted Kidney Organoids 

Pioneer bioprinting company Organovo presented new findings in their stem-cell-based approach to developing kidney tissue using its 3D bioprinting platform, the NovoGen Bioprinter. During the annual meeting for The International…

Organovo: Bioprinting Could be the New Solution to Organ Transplantation

Remember when movies like The Island seemed like a scary yet foreseeable future? In 2005, the sci-fi thriller introduced a compound inhabited by clones used for organ harvesting, as well…

R&D Profiles of Leading 3D Printing Companies

It is important to analyze the level of the R&D occurring at the leading 3D printer manufacturers to help understand the technology commitment and future growth prospects of the 3D…

3D Printing News Briefs: December 27, 2017

Just because Christmas was two days ago doesn’t mean that the 3D printing industry has been taking a break. In today’s 3D Printing News Briefs, we’ll be covering the latest…

Organovo & Viscient Biosciences Collaborate for 3D Bioprinting in Liver Disease Research

Earlier this month, both Organovo and Viscient Biosciences announced their intent to collaborate on research for further studies into liver disease. There have been many interesting stories about Organovo and…

View More